fbpx
Asian Dengue Voice and Action

News

Prof. Tikki Pang (Advisor for ADVA) highlights the intensified vector control strategies in Singapore and illustrates its impact on dengue control

2023-03-17T18:29:34+08:00

SINGAPORE — With the number of dengue cases steadily declining, Singapore looks set to avoid the worst-case scenario of a record 30,000 cases predicted by the authorities at the start of the year, when cases spiked alarmingly. Read more at https://www.todayonline.com/singapore/dengue-cases-2016-figures-be-lower-expected

Prof. Tikki Pang (Advisor for ADVA) highlights the intensified vector control strategies in Singapore and illustrates its impact on dengue control2023-03-17T18:29:34+08:00

Dato’ Dr. Musa Mohd Nordin voices his concerns on the delay of dengue vaccine approval in Malaysia and urges the Government of Malaysia to take immediate steps to approve this life-saving vaccine.

2023-03-17T18:29:35+08:00

Historically, Malaysia was foremost to document Dengue Fever (DF) in 1902 and Dengue Haemorrhagic Fever (DHF) in1962. It would have been another feather in our national cap [Read More...]

Dato’ Dr. Musa Mohd Nordin voices his concerns on the delay of dengue vaccine approval in Malaysia and urges the Government of Malaysia to take immediate steps to approve this life-saving vaccine.2023-03-17T18:29:35+08:00

ADVA Group comments on the recent dengue update :

2023-03-17T18:29:35+08:00

Rapid urbanisation, climate change and poor vector control will continue to cause a rise in the number of dengue infections. Singapore’s Health Sciences Authority's recent dengue vaccine approval together with vector control measures will play a crucial role in helping to combat the spread of the virus. Proper education on mosquito breeding areas and avoidance of activities during times when the mosquito comes out to feed at dawn and dusk, use of repellents and wearing bright coloured clothes will help in reducing the chance of getting infected.

ADVA Group comments on the recent dengue update :2023-03-17T18:29:35+08:00

Asian Strategic Alliance for Pneumococcal Disease Prevention Symposium at the 8th Asian Congress of Paediatric Infectious Diseases 2016

2023-03-17T18:29:35+08:00

Event Date   : 10th November 2016Event Venue: Queen Sirikit Convention                            Centre,Bangkok, ThailandSymposium Title: Pneumococcal Vaccine                                   15 years onTime               : 10.30 - 12.00 Read More

Asian Strategic Alliance for Pneumococcal Disease Prevention Symposium at the 8th Asian Congress of Paediatric Infectious Diseases 20162023-03-17T18:29:35+08:00

Asian Dengue Vaccination Advocacy Symposium at the 8th Asian Congress of Paediatric Infectious Diseases 2016

2023-03-17T18:29:35+08:00

Event Date   : 9 Nov 2016Event Venue: Queen Sirikit Convention                            Centre,Bangkok, ThailandSymposium Title: From Dengue Vaccine                             to Dengue VaccinationTime               : 13.30 - 15.00 Read More

Asian Dengue Vaccination Advocacy Symposium at the 8th Asian Congress of Paediatric Infectious Diseases 20162023-03-17T18:29:35+08:00

Singapore to make Dengue Vaccine Soon available – HSA reports:

2023-03-17T18:29:36+08:00

SINGAPORE - The Health Sciences Authority (HSA) has approved the world's first dengue vaccine Dengvaxia for use in Singapore following a seven-month expedited review of the potential [Read More...]

Singapore to make Dengue Vaccine Soon available – HSA reports:2023-03-17T18:29:36+08:00

ADVA congratulates Dr. Garin, Honorable Health Secretary, Republic of the Philippines on the launch of the first mass dengue vaccination programme

2023-03-17T18:29:37+08:00

The Philippines leads the path to better dengue management with the world's first mass vaccination programme for dengue fever. ADVA is pleased to congratulate Dr. Loreto-Garin, Health Secretary and the people involved for their accomplishment.

ADVA congratulates Dr. Garin, Honorable Health Secretary, Republic of the Philippines on the launch of the first mass dengue vaccination programme2023-03-17T18:29:37+08:00
Go to Top